Daniel P. Gold
2022
In 2022, Daniel P. Gold earned a total compensation of $2.5M as President, Chief Executive Officer and Director at MEI Pharma, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $275,184 |
|---|---|
| Option Awards | $1,536,800 |
| Salary | $716,625 |
| Total | $2,528,609 |
Gold received $1.5M in option awards, accounting for 61% of the total pay in 2022.
Gold also received $275.2K in non-equity incentive plan and $716.6K in salary.
Rankings
In 2022, Daniel P. Gold's compensation ranked 1,435th out of 5,736 executives tracked by ExecPay. In other words, Gold earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,435 out of 5,736 | 75th |
Division Manufacturing | 716 out of 3,125 | 77th |
Major group Chemicals And Allied Products | 279 out of 1,416 | 80th |
Industry group Drugs | 258 out of 1,317 | 80th |
Industry Pharmaceutical Preparations | 181 out of 963 | 81st |
Source: SEC filing on October 27, 2022.
Gold's colleagues
We found three more compensation records of executives who worked with Daniel P. Gold at MEI Pharma in 2022.